Minhu J. Chen

Minhu J. Chen

58 Zhongshan II Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 154 publications

Chinese expert consensus on extraintestinal manifestations of inflammatory bowel disease.

Chinese expert consensus on extraintestinal manifestations of inflammatory bowel disease.

Journal: Intestinal research

Published: April 22, 2026

Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn's disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials.

Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn's disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials.

Journal: Intestinal research

Published: July 22, 2025

Fibroblast pentose phosphate pathway activation upon decreased circPLCE1 exacerbates intestinal fibrosis in Crohn's disease.

Fibroblast pentose phosphate pathway activation upon decreased circPLCE1 exacerbates intestinal fibrosis in Crohn's disease.

Journal: Gut

Published: July 13, 2025

Comparative study on simultaneous bilateral and unilateral posterior vocal cord resection using CO2 laser for bilateral vocal cord paralysis

Comparative study on simultaneous bilateral and unilateral posterior vocal cord resection using CO2 laser for bilateral vocal cord paralysis

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: April 03, 2025

Characteristics and predictors of technically difficult peroral endoscopic myotomy in esophageal motility disorders: a high-volume center analysis of 676 procedures.

Characteristics and predictors of technically difficult peroral endoscopic myotomy in esophageal motility disorders: a high-volume center analysis of 676 procedures.

Journal: Surgical endoscopy

Published: February 24, 2025

Development and validation of a nomogram for predicting endoscopic healing in crohn's disease patients receiving infliximab treatment.

Development and validation of a nomogram for predicting endoscopic healing in crohn's disease patients receiving infliximab treatment.

Journal: BMC gastroenterology

Published: February 24, 2025

Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study.

Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 21, 2024

Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)

Experts consensus on standard items of the cohort construction and quality control of temporomandibular joint diseases (2024)

Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology

Published: September 30, 2024

Novel loss-of-function intronic mutation in ELF4 is associated with intestinal autoinflammation.

Novel loss-of-function intronic mutation in ELF4 is associated with intestinal autoinflammation.

Journal: Mucosal immunology

Published: September 05, 2024

Decoding polyphenol metabolism in patients with Crohn's disease: Insights from diet, gut microbiota, and metabolites.

Decoding polyphenol metabolism in patients with Crohn's disease: Insights from diet, gut microbiota, and metabolites.

Journal: Food research international (Ottawa, Ont.)

Published: May 31, 2024

Identification of gastroenteropancreatic neuroendocrine tumor patients with high liver tumor burden based on clinicopathological features.

Identification of gastroenteropancreatic neuroendocrine tumor patients with high liver tumor burden based on clinicopathological features.

Journal: BMC cancer

Published: May 16, 2024

The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial.

The efficacy of keverprazan-based quadruple therapy for Helicobacter pylori eradication: A phase III, randomised, double-blind, multicentre trial.

Journal: International journal of antimicrobial agents

Published: April 10, 2024

Showing 1-12 of 154

Last Updated: 09/26/2026